119th Congress · introduced in the Senate · Mar 13, 2025
Improving Access to Addiction Medicine Providers Act
Official title from Congress.gov
Latest action (Mar 13, 2025): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
View on Congress.govPolicy area: Health
Congressional Research Service summary, version: Introduced in Senate (Mar 13, 2025)
Improving Access to Addiction Medicine Providers Act
This bill provides statutory authority for the Minority Fellowship Program to include fellowships for training in the field of addiction medicine. (The Minority Fellowship Program, administered by the Substance Abuse and Mental Health Services Administration, funds fellowships for individuals seeking graduate degrees and planning to work on addressing mental or substance use disorders in racial and ethnic minority populations.)
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026.
9 citations.
BLUE CROSS AND BLUE SHIELD OF FLORIDA INC · lobbying firm or registrant: BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC.
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Jul 22, 2025 · issue area: Pharmacy
$120,000
Spent on own lobbying
…ubmissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office. Sponsor: Sen. Hassan, Margaret Wood [D-NH] S.1036 - Improving Access to Addiction Medicine Providers Act To amend the Public Health Service Act to authorize fellowships under the Minority Fellowship Program to…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BLUE CROSS AND BLUE SHIELD OF KANSAS INC · lobbying firm or registrant: BLUE CROSS AND BLUE SHIELD OF KANSAS, INC.
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Jul 21, 2025 · issue area: Pharmacy
$10,000
Spent on own lobbying
…ubmissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office. Sponsor: Sen. Hassan, Margaret Wood [D-NH] S.1036 - Improving Access to Addiction Medicine Providers Act To amend the Public Health Service Act to authorize fellowships under the Minority Fellowship Program to…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BLUE CROSS AND BLUE SHIELD ASSOCIATION · lobbying firm or registrant: BLUE CROSS AND BLUE SHIELD ASSOCIATION
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Jul 21, 2025 · issue area: Pharmacy
$1,210,000
Spent on own lobbying
…ubmissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office. Sponsor: Sen. Hassan, Margaret Wood [D-NH] S.1036 - Improving Access to Addiction Medicine Providers Act To amend the Public Health Service Act to authorize fellowships under the Minority Fellowship Program to…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN SOCIETY OF ADDICTION MEDICINE · lobbying firm or registrant: AMERICAN SOCIETY OF ADDICTION MEDICINE
2025 Q1 report (Jan 1, 2025 – Mar 31, 2025) · posted Apr 18, 2025 · issue area: Alcohol and Drug Abuse
$50,000
Spent on own lobbying
…S Act (HR 1627) to amend the Controlled Substances Act to allow for the use of telehealth in substance use disorder treatment, and for other purposes. Endorsed S. 1036, improving access to addiction medicine providers by amending the Public Health Service Act to authorize fellowships under the Minority Fellowship Program to b…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN SOCIETY OF ADDICTION MEDICINE · lobbying firm or registrant: AMERICAN SOCIETY OF ADDICTION MEDICINE
2025 Q1 report (Jan 1, 2025 – Mar 31, 2025) · posted Apr 18, 2025 · issue area: Health Issues
$50,000
Spent on own lobbying
…S Act (HR 1627) to amend the Controlled Substances Act to allow for the use of telehealth in substance use disorder treatment, and for other purposes. Endorsed S. 1036, improving access to addiction medicine providers by amending the Public Health Service Act to authorize fellowships under the Minority Fellowship Program to b…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN SOCIETY OF ADDICTION MEDICINE · lobbying firm or registrant: AMERICAN SOCIETY OF ADDICTION MEDICINE
2025 Q1 report (Jan 1, 2025 – Mar 31, 2025) · posted Apr 18, 2025 · issue area: Medical/Disease Research/Clinical Labs
$50,000
Spent on own lobbying
…S Act (HR 1627) to amend the Controlled Substances Act to allow for the use of telehealth in substance use disorder treatment, and for other purposes. Endorsed S. 1036, improving access to addiction medicine providers by amending the Public Health Service Act to authorize fellowships under the Minority Fellowship Program to b…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN SOCIETY OF ADDICTION MEDICINE · lobbying firm or registrant: AMERICAN SOCIETY OF ADDICTION MEDICINE
2025 Q1 report (Jan 1, 2025 – Mar 31, 2025) · posted Apr 18, 2025 · issue area: Medicare/Medicaid
$50,000
Spent on own lobbying
…S Act (HR 1627) to amend the Controlled Substances Act to allow for the use of telehealth in substance use disorder treatment, and for other purposes. Endorsed S. 1036, improving access to addiction medicine providers by amending the Public Health Service Act to authorize fellowships under the Minority Fellowship Program to b…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN SOCIETY OF ADDICTION MEDICINE · lobbying firm or registrant: AMERICAN SOCIETY OF ADDICTION MEDICINE
2025 Q1 report (Jan 1, 2025 – Mar 31, 2025) · posted Apr 18, 2025 · issue area: Budget/Appropriations
$50,000
Spent on own lobbying
…S Act (HR 1627) to amend the Controlled Substances Act to allow for the use of telehealth in substance use disorder treatment, and for other purposes. Endorsed S. 1036, improving access to addiction medicine providers by amending the Public Health Service Act to authorize fellowships under the Minority Fellowship Program to b…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN SOCIETY OF ADDICTION MEDICINE · lobbying firm or registrant: AMERICAN SOCIETY OF ADDICTION MEDICINE
2025 Q1 report (Jan 1, 2025 – Mar 31, 2025) · posted Apr 18, 2025 · issue area: Insurance
$50,000
Spent on own lobbying
…S Act (HR 1627) to amend the Controlled Substances Act to allow for the use of telehealth in substance use disorder treatment, and for other purposes. Endorsed S. 1036, improving access to addiction medicine providers by amending the Public Health Service Act to authorize fellowships under the Minority Fellowship Program to b…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing